Extended Viewer

Arihant Jain

Arihant Jain

Associate, MSCI Research

Arihant Jain is a specialist in quantitative research that supports new and existing indexes, including factor indexes. Previously, he worked as an analyst at Morgan Stanley. Arihant holds a bachelor’s degree in chemical engineering from the Birla Institute of Technology and Science, Pilani. He is a CFA® charterholder.

Research and Insights

Articles by Arihant Jain

    Value’s Lost Decade

    Research Report | May 6, 2022 | Mehdi Alighanbari , Arihant Jain , Saurabh Katiyar , Waman Virgaonkar

    Value rebounded in 2021, after more than a decade of lackluster performance. No matter what the expectation going forward, there are useful lessons to be learned from value strategies’ behavior over the past two decades.

    How a Shift Toward Buybacks Affected Yield Strategies

    6 mins read Blog | Sep 3, 2021 | Mehdi Alighanbari , Arihant Jain

    For investors who use yield strategies to generate income, a steady stream of dividend payments is important. But with more companies using buybacks as a way to redistribute profits, investors may want to consider a more holistic view of income.

    Fresh IPO Stocks and Indexes: In or Out?

    6 mins read Blog | Aug 3, 2021 | Arihant Jain , Mehdi Alighanbari

    Depending on a number of factors, stocks may be added to indexes soon after a company’s IPO, which can affect asset managers who use the indexes to create and benchmark portfolios. We investigate the impact of IPO stocks on index performance.

    Escaping to Equities for Yield

    6 mins read Blog | Jun 10, 2021 | Arihant Jain , Mehdi Alighanbari

    In today’s low-rate world, some investors shifted toward historically higher-yielding equities. For others, especially in the insurance industry, the greater risk limited their ability to do so. Was a minimum-variance equity approach a viable option?

    Bringing Value to the 21st Century

    8 mins read Blog | Apr 28, 2021 | Arihant Jain , Mehdi Alighanbari , Saurabh Katiyar , Katiyar Saurabh

    In the second post in our series, we further probe value’s underperformance over the past decade and ask if the historic definition of value remains relevant. We specifically look at whether a company’s valuation can be enhanced by reflecting R&D investments.